NAD IV Therapy: What Does It Actually Do?

NAD stands for nicotinamide adenine dinucleotide. It is naturally present inside your cells. Your body uses NAD in several important biological processes.

One of the best-known roles involves cellular energy. The food you eat has to be converted into energy your cells can use. NAD participates in the chemical reactions involved in that process.

This biology is well established. But NAD being important inside your cells does not automatically prove that putting extra NAD into a vein improves every process that depends on NAD.

• cellular metabolism
• mitochondrial function
• redox reactions
• DNA-related processes
• cell signalling
• normal enzyme activity

NAD IV therapy involves administering NAD intravenously through an IV line. That allows the administered substance to enter the circulation without first passing through the digestive system.

But IV administration creates another question: what happens to NAD once it enters the bloodstream? Researchers are still working that out.

A small pharmacokinetic study showed that intravenous NAD influences NAD-related metabolites and is biologically active. However, pharmacokinetic findings tell researchers what happens to a substance in the body. They do not prove that the treatment makes people younger, more energetic or mentally sharper.

Recent scientific reviews continue to describe IV NAD research as limited compared with the amount of commercial attention it receives.

The interest comes from several areas of ageing and metabolism research. Scientists have studied NAD-related pathways because they are connected with energy metabolism, mitochondrial function, cellular stress responses, DNA-related processes, inflammation and biological ageing.

Researchers have also studied compounds that influence NAD metabolism, including NAD precursors such as nicotinamide riboside, commonly called NR, and nicotinamide mononucleotide, or NMN. Some studies show that these compounds can increase NAD-related metabolites in the body.

That is scientifically interesting. The difficult part is determining whether changing those biomarkers creates meaningful health improvements.

A 2026 systematic review found that oral NR and NMN can change NAD-related biomarkers, but effects on physical function, metabolism, cardiovascular outcomes and other health measures have been inconsistent. For intravenous NAD itself, the evidence was even more limited.

You will often see a simple statement online: “NAD falls as you age.” The real picture is more complicated. Ageing research has found changes in NAD metabolism in different tissues and biological systems.

But newer evidence suggests that saying every healthy person experiences a simple, predictable decline in whole-blood NAD with age may be too simplistic. A recent 2026 review specifically noted that large human datasets do not support treating declining whole-blood NAD as a universal feature of healthy ageing.

This matters because a common sales argument is: “You are getting older, therefore your NAD must be low, therefore you need an NAD infusion.” Human biology is not that simple. Age alone does not tell you whether an NAD IV will improve your health.

This is probably one of the biggest claims around NAD therapy. NAD participates in the cellular reactions involved in energy metabolism. Therefore, people assume: more NAD equals more energy. But biology does not always work in a straight line like that.

Increasing the availability of something involved in an energy pathway does not prove that a person will suddenly feel more energetic. The current evidence does not establish IV NAD as a proven treatment for everyday tiredness or low energy in healthy adults.

Recent reviews conclude that clinical benefit remains uncertain because studies are small, methods differ and strong placebo-controlled IV trials are lacking. Some people receiving NAD infusions may report feeling different. That is not the same as having strong evidence that NAD reliably treats fatigue.

If you feel tired for weeks or months, it is also important not to assume that low NAD is the reason. Persistent fatigue can have many possible causes.

NAD is involved in normal nervous-system and cellular processes, so researchers are interested in its possible relationship with brain health and neurodegenerative conditions. But there is currently a big gap between biological interest and proven clinical benefit.

Some small or exploratory studies have reported changes in neurological symptoms or self-reported outcomes. However, recent reviews say these findings are not strong enough to prove that IV NAD improves cognition, memory or brain performance in healthy adults.

If someone tells you that NAD improves memory, eliminates brain fog or makes your brain perform better, ask the questions below. They often reveal how much of the claim comes from actual clinical evidence and how much comes from marketing.

• Compared with what?
• In what type of patients?
• In how many people?
• Was there a placebo group?
• Was the improvement objectively measured?

This claim needs even more caution. NAD-related pathways are genuinely studied in ageing science. That makes NAD interesting to researchers. But an interesting ageing pathway is not the same as a proven anti-ageing treatment.

A 2026 systematic review examined NAD supplementation for anti-ageing and wellness. It found evidence that some NAD-related interventions can change biochemical markers. But it did not find eligible clinical outcome trials demonstrating that IV NAD itself improves anti-ageing or wellness outcomes. The authors concluded that human clinical effectiveness remains uncertain.

Another 2026 review of intravenous longevity therapies reached a similar conclusion. There is biological rationale and early research, but there is not yet strong clinical evidence proving that intravenous NAD extends lifespan, reverses ageing or reliably improves validated measures of biological ageing.

Claims such as “Reverse ageing”, “Turn back your biological clock” or “Live longer” go further than the evidence allows.

NAD is involved in normal cellular processes connected with enzymes that participate in DNA maintenance and repair. That is true. But saying “NAD is involved in DNA repair” is different from saying “An NAD IV repairs your DNA.”

The second statement requires evidence showing that giving NAD intravenously creates a meaningful clinical DNA-repair benefit in people. That evidence has not been established.

A substance can participate in a biological pathway without supplementation automatically improving that pathway beyond normal physiology.

NAD has an important role in metabolism. Researchers have therefore studied NAD-related interventions in areas such as glucose metabolism, mitochondrial health and age-related metabolic changes. Results in humans are mixed.

Recent research on oral NAD precursors shows that the biochemical effect can be measurable while the actual clinical outcomes are inconsistent.

A small 2026 real-world study comparing intravenous NAD with intravenous nicotinamide riboside also examined metabolic markers. Some laboratory changes occurred, but the researchers described the findings as exploratory and said more research is needed before conclusions about effectiveness can be made.

A change in a laboratory marker should not automatically be translated into “Your metabolism has improved.” That requires stronger evidence.

There is no medically reliable answer such as “You will feel NAD within 30 minutes.” People may report different experiences during or after an infusion. Some may notice nothing obvious.

The response can depend on the dose, administration rate, formulation, individual health and what outcome the person is expecting. More importantly, current research has not established a standard timeframe in which healthy adults should expect a meaningful clinical benefit from IV NAD.

Be cautious when a guaranteed timeframe is used as a sales promise.

There is no established universal answer. Claims that one NAD infusion provides benefits for a specific number of days or weeks are not supported by strong clinical evidence.

Researchers are still studying how IV NAD is metabolised, how circulating NAD-related compounds change, which tissues are affected, whether those changes create meaningful outcomes, and how long any clinically meaningful effects may last.

Until those questions are answered better, a precise “NAD lasts X days” promise is more marketing than established medicine.

There is no evidence-based schedule that applies to everyone. You may see programmes recommending several infusions close together, weekly NAD, monthly NAD or repeated maintenance treatments.

But recent reviews specifically note that optimal IV NAD dosing and treatment schedules have not been established through strong clinical trials. A schedule should not be chosen simply because a package says “Four sessions recommended.”

The reason for treatment, formulation, health history and available evidence should come first.

No evidence supports that assumption. More is not automatically better. NAD metabolism is regulated by complex biological systems. Responses are not necessarily linear: doubling the dose does not establish double the benefit.

This matters especially with IV therapy. Higher doses can also affect tolerability. A treatment should not become a competition to receive the biggest number on the IV bag.

Long-term data are limited. That is one of the biggest gaps in the current evidence. Most available studies are relatively small or short.

Researchers do not yet have the type of large, long-term controlled evidence that would allow strong conclusions about repeated IV NAD treatment over many months or years. Recent reviews specifically identify long-term safety as an area requiring further research.

That should matter when NAD is promoted as something a healthy person should continue indefinitely.

We do not have enough evidence to make a simple statement that IV NAD is “better”. Different approaches exist, including direct NAD, nicotinamide riboside (NR), nicotinamide mononucleotide (NMN), and other compounds involved in NAD metabolism.

Oral NR and NMN have actually been studied more extensively in humans than direct intravenous NAD for wellness outcomes. Studies show that they can influence NAD-related biomarkers. But even there, improvements in meaningful clinical outcomes are inconsistent.

Bypassing the digestive system does not automatically mean a better result, better health or better value. Route of administration is only one part of the question.

There is currently no standard wellness pathway where a simple NAD blood test can tell you: “You are low in NAD, therefore you need an NAD IV.”

NAD biology differs across blood, cells and tissues. A blood measurement does not necessarily describe what is happening inside every tissue in the body. The relationship between measured NAD levels and the outcomes people want from wellness therapy is still an area of research.

Be cautious with any model that turns a single NAD number into an automatic treatment recommendation.

NAD research has explored fatigue-related areas, but that does not make IV NAD an established treatment for unexplained chronic fatigue. If someone has persistent fatigue, the first question should still be: why am I tired?

Jumping directly from “I feel exhausted” to “I need NAD” can skip the most important part of the process.

• sleep problems
• anaemia or iron deficiency
• thyroid conditions
• medications
• blood sugar problems
• mental health
• nutritional issues
• other medical conditions
• several factors occurring together

There is currently not enough evidence to say that healthy adults need routine NAD IV therapy. This does not mean researchers have proven NAD IV has no effects.

It means the evidence is not strong enough to support broad claims that healthy people should receive NAD infusions to prevent ageing, maintain brain function or increase energy.

“Not proven” does not mean “impossible”. But it also does not mean “Probably works, so everyone should try it.” More high-quality human research is needed.

Before deciding, ask practical questions. These questions are more useful than simply asking “Which NAD package should I buy?”

• What exactly is in the IV?
• How much NAD is included?
• Are there other vitamins, minerals or ingredients?
• Why is this formulation being recommended for me?
• What evidence supports the result I want?
• What side effects can happen?
• Who reviews my medical history?
• Could any of my medicines matter?
• Who monitors me during the infusion?
• What happens if I develop symptoms?
• Why is this frequency being recommended?

AAMC includes NAD within its broader Wellness for VIP IV formulation. This is an important distinction. NAD should not be positioned as a proven standalone anti-ageing treatment.

The Wellness for VIP formulation contains NAD together with vitamins, minerals, amino acids and other nutrients involved in normal cellular and metabolic processes.

The formulation includes nutrients involved in normal energy metabolism, antioxidant defence, immune function, muscle and nerve function, and normal cellular processes. NAD is one component of that wider formulation. Its presence does not mean the IV has been proven to reverse ageing, cure fatigue or improve brain performance.

Wellness for VIP is AAMC's broader wellness-focused formulation. It contains a combination that includes the nutrients below, and other nutrients.

These substances have established biological roles in the human body. That should not be confused with claiming that the combined IV has been clinically proven to produce every wellness outcome associated with those biological pathways.

The formulation is not a replacement for diagnosing or treating an underlying medical condition.

• Vitamin C
• Vitamin D3
• B vitamins
• Magnesium
• Zinc
• Amino acids
• NAD

Because the formulation is only one part of the decision. A clinician may also need to understand why you are considering IV therapy, your current symptoms, medical history, regular medicines, supplements, allergies, previous reactions and relevant medical results.

At AAMC, IV therapy is provided inside Advance American Medical Center rather than as a standalone drip-bar service. The final IV plan is confirmed after medical review.

Then the treatment should not be forced. Imagine someone books because they have been exhausted for six months. They may arrive asking for NAD because they read that NAD supports cellular energy.

But if the real problem is poor sleep, an iron deficiency, a thyroid issue, a medicine side effect or another health concern, simply focusing on NAD may miss what actually needs attention.

That is why medical review adds value. The purpose is not just to approve the treatment someone saw online. It is to decide whether that treatment makes sense.